Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FZK77
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,993
Award facts
- Contract value 100% obligated
- $20,993.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,993.31 by the Defense Logistics Agency on August 6, 2025, for the supply of Alyftrek 10-50-125 mg tablets (14-unit packages). The contract, which carries no set-aside designation, is scheduled for ultimate completion by August 7, 2025, and will be performed at the company's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established itself as a preferred vendor for the Defense Logistics Agency, with a robust portfolio of delivery orders covering prescription medications, biologics, vaccines, and medical consumables. The company's federal contracting history demonstrates consistent success in competing for pharmaceutical supply requirements across the Department of Defense healthcare system without relying on specific set-aside designations, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Quick answers
Who was awarded contract SPE2DB25FZK77?
SPE2DB25FZK77 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FZK77 worth?
The government has obligated $20,993 on SPE2DB25FZK77.
Is contract SPE2DB25FZK77 an order under another contract?
Yes. SPE2DB25FZK77 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZK77 competed?
The extent of competition for SPE2DB25FZK77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award